
Loading, please wait...

Loading, please wait...

Abbott recently announced the launch of its TriClip TEER system in India. This technology represents a major shift in managing tricuspid regurgitation (TR), often called a leaky heart valve. Because TR often affects patients unsuitable for surgery, this device offers a vital alternative. Consequently, Indian cardiologists now have a specialized tool for right-sided heart valve repair.
The system utilizes a transcatheter edge-to-edge repair technique. Specifically, doctors deliver the device through a vein in the leg. Once it reaches the heart, the clip pulls the valve leaflets together. This action reduces the backflow of blood significantly. Because the procedure is minimally invasive, most patients return home after just one day in the hospital.
The USFDA approved this technology based on the TRILUMINATE Pivotal trial. This study showed that 90% of patients experienced a reduction in TR severity. Furthermore, these benefits remained stable during a one-year follow-up period. Two-year data also indicated a 28% reduction in heart failure hospitalizations. Therefore, the device offers long-term improvements in quality of life for those with severe valve leakage.
In India, TR is frequently linked to rheumatic heart disease and atrial fibrillation. However, clinicians often overlook this condition because symptoms develop slowly. Patients might only notice fatigue or shortness of breath as the disease progresses. Consequently, early intervention with the TriClip TEER system could prevent complications like heart failure or permanent organ damage.
Q1: Who is an ideal candidate for the TriClip procedure?
Patients with symptomatic severe tricuspid regurgitation who are at intermediate or high risk for traditional open-heart surgery are typical candidates.
Q2: How long is the recovery period after the procedure?
Most patients require only about a day of hospitalization and can return to their daily activities much faster than after open surgery.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Abbott introduces the TriClip TEER system in India, offering a minimally invasive option for treating leaky tricuspid valves without open-heart surgery....
2 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today